Potential for earlier diagnosis of ovarian cancer

January 25, 2012 in Cancer

(Medical Xpress) -- Australian scientists have identified biochemical changes that commonly occur in the DNA of women with ovarian cancer, which may help diagnose the cancer at an earlier stage in the future.

Using whole genome methods, Brian Gloss, Dr Philippa O’Brien and Professor Susan Clark from Sydney’s Garvan Institute of Medical Research have identified a panel of 6 genes that are affected by an epigenetic process known as ‘ DNA methylation’ in .

The Garvan team collaborated with Professor Neville Hacker, Director Gynaecological Cancer Unit, Royal Hospital for Randwick, who provided tumour samples from ovarian cancer patients, as well as tissue samples from normal ovaries.

The findings are published in the journal Cancer Letters, now online.

Ovarian cancer is not easily diagnosed early, and people with advanced disease tend to die quickly.

Women diagnosed at a late stage – the majority – have a 30% 5-year survival rate. Women diagnosed at an early stage have a 90% 5-year survival rate.

Although ovarian cancer is a relatively rare disease, it is the leading cause of death due to gynaecological cancers, and the sixth leading cause of cancer death in women. Around one in 70 women will develop the cancer, and around one in 100 women will die from it.

Ovarian cancers are usually diagnosed once the disease has spread past the pelvis and into other organs including the stomach, bowel and lungs. They are typically very hard to get rid of with surgery and they tend to become rapidly resistant to chemotherapeutics.

“This was one of first studies that used whole genome techniques to directly profile DNA methylation aberrations in ovarian cancer - with the aim of identifying diagnostic biomarkers,” said Brian Gloss, who focused on the project for his PhD.

“When we started in 2008, most other research groups were investigating single genes known to be methylated in other cancers. We decided to make use of new whole genome technologies – using DNA methylation profiling and gene expression profiling.”

“We wanted to see exactly which methylation changes led directly to aberrant gene silencing. In other words, which methylation changes have a functional role in ovarian cancer.”

“We did our discovery process in cell lines and then validated our findings in 27 cancers versus 12 normal ovarian tissue samples.”

“One of the key methylated genes we identified was a novel gene, which had not been identified as being misregulated in any cancer before.”

“When we then analysed a further 100 tumours, we found that the novel biomarker gene was methylated in 80% of them.”

“This paper represents the first half of our work. The next step will be to see how our panel of biomarker genes is methylated in a larger cohort of ovarian tumours, and to identify the function of our novel gene.”

“The most difficult aspect of ovarian cancer is that it is a molecularly heterogeneous disease, meaning that each tumour can be quite different from the next.”

“We need to show, therefore, that our panel of biomarkers will be a sufficiently rigorous diagnostic tool, able to catch the requisite number of tumours.

More information: www.mendeley.com/r… l-novel-pan/

Provided by Garvan Institute of Medical Research

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

Hormone replacement therapy—clarity at last

The British Menopause Society and Women's Health Concern have today released updated guidelines on Hormone Replacement Therapy (HRT) to provide clarity around the role of HRT, the benefits and the risks. The new guidelines ...

Cancer created 2 minutes ago | popularity not rated yet | comments 0

Research identifies a way to make cancer cells more responsive to chemotherapy

Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to. New research from Western University ...

Cancer created 11 hours ago | popularity 5 / 5 (3) | comments 0

Mayo Clinic genomic analysis lends insight to prostate cancer

Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings ...

Cancer created 11 hours ago | popularity not rated yet | comments 0

When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs

Even while being dragged to its destruction inside a cell, a cancer-promoting growth factor receptor fires away, sending signals that thwart the development of tumor-suppressing microRNAs (miRNAs) before it's dissolved, researchers ...

Cancer created 12 hours ago | popularity not rated yet | comments 0 | with audio podcast

Improved chemo regimen for childhood leukemia may offer high survival, no added heart toxicity

Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added ...

Cancer created 16 hours ago | popularity not rated yet | comments 0


Controlling mood through the motions of mitochondria

(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...

Motion quotient: IQ predicted by ability to filter motion (w/ video)

A brief visual task can predict IQ, according to a new study. This surprisingly simple exercise measures the brain's unconscious ability to filter out visual movement. The study shows that individuals whose ...

Multiple research teams unable to confirm high-profile Alzheimer's study

Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.

Scientists discover molecule triggers sensation of itch

Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...

Researchers find common childhood asthma unconnected to allergens or inflammation

Little is known about why asthma develops, how it constricts the airway or why response to treatments varies between patients. Now, a team of researchers at Weill Cornell Medical College, Columbia University Medical Center ...

Diabetes' genetic underpinnings can vary based on ethnic background, studies say

Ethnic background plays a surprisingly large role in how diabetes develops on a cellular level, according to two new studies led by researchers at the Stanford University School of Medicine.